Other compounds, such as Mycro3 and KJ-Pyr-9, target the interaction between Myc-Max and blocks the formation of the Myc-Max-DNA complex and were active in Myc-amplified human pancreatic and breast cancer cell xenografts [33]. Here, MYC is linked to breast cancer.